Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins

Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is considered as a promising vaccination approach against human immunodeficiency virus (HIV-1). To further enhance the efficacy of DNA-rMVA vaccination, we investigated humoral and cellular immune respon...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Main Authors: Gangadhara, Sailaja, Kwon, Young-Man, Jeeva, Subbiah, Quan, Fu-Shi, Wang, Baozhong, Moss, Bernard, Compans, Richard W., Amara, Rama Rao, Jabbar, M. Abdul, Kang, Sang-Moo
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748618/
https://ncbi.nlm.nih.gov/pubmed/29257056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines5040052
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares